Clinical case of long-term use of osimertinib in the treatment of EGFR mutation-positive lung adenocarcinoma

This article reviews clinical case of epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer and the usage of osimertinib for its treatment. Targeted drugs, EGFR tyrosine kinase inhibitors were approved for the treatment of non-small cell lung cancer more than 15 years...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Svetlana V. Odintsova, Mariia A. Sviridenko, Antonina O. Cheremnykh, Elena A. Filippova, Magaripa A. Urtenova, Sergei V. Orlov
Formato: article
Lenguaje:RU
Publicado: IP Habib O.N. 2020
Materias:
Acceso en línea:https://doaj.org/article/35b34aa048204aa58f62d993ec1f67bc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!